This inventor holds 4 USPTO granted patents. Top assignee: G.d. Searle & Company. Active years: 1986-1991.
Company Filing History:
Years Active: 1986-1991
Title: Thomas J Lindberg: Innovator in Hyperlipidemia Treatment
Introduction
Thomas J Lindberg is a notable inventor based in Wheaton, IL (US). He has made significant contributions to the field of medicine, particularly in the treatment of hyperlipidemia. With a total of 4 patents to his name, Lindberg's work has the potential to impact many lives.
Latest Patents
Lindberg's latest patents focus on substituted glutaric acid lactones in the treatment of hyperlipidemia. These compounds are designed to inhibit the formation of serum cholesterol by targeting .beta.-hydroxy-.beta.-methylglutaryl-CoA (HMG CoA), which is a key substance in the synthesis of serum cholesterol. His innovative approach aims to provide effective solutions for managing cholesterol levels.
Career Highlights
Throughout his career, Lindberg has been associated with G.D. Searle & Company, where he has furthered his research and development efforts. His work has been instrumental in advancing medical treatments and improving patient outcomes.
Collaborations
Lindberg has collaborated with notable coworkers such as John S Baran and Harman S Lowrie. These partnerships have contributed to the success of his projects and the development of his patents.
Conclusion
Thomas J Lindberg's contributions to the field of hyperlipidemia treatment through his innovative patents highlight his dedication to medical advancements. His work continues to pave the way for future research and development in this important area.